Ugradar, Shoaib
Kang, Julia
Kossler, Andrea L.
Zimmerman, Erin
Braun, Jenna
Harrison, Andrew R.
Bose, Swaraj
Cockerham, Kimberly
Douglas, Raymond S.
Article History
Received: 23 March 2021
Revised: 27 April 2021
Accepted: 30 April 2021
First Online: 9 July 2021
Conflict of interest
: RD—Consultant Horizon Therapeutics, Immunovant Corporation, Veridian Corporation. KC—Consultant Horizon Therapeutics, Viridian Pharmaceuticals and 3T Ophthalmics. AH-Consultant Horizon Therapeutics, Osmotica Pharmaceuticals. AK—Consultant Horizon Therapeutics, Osmotica Pharmaceuticals, Immunovant Corporation, Axogen Corporation. Horizon Therapeutics funded the publication fees after the article was accepted for publication.